Table 1 Characteristics of the patients at the two study sites
From: HIV care in Yangon, Myanmar; successes, challenges and implications for policy
Variable | All n = 2643 | Waibargi Hospital n = 1674 | Insein Hospital n = 969 | p^ |
|---|---|---|---|---|
Age | 37 (31–44) | 38 (32–45) | 35 (29–41) | <0.001 |
Gender (% male) | 1494 (57%) | 1011 (60%) | 483 (50%) | <0.001 |
Unemployed | 917 (35%) | 453 (27%) | 464 (48%) | <0.001 |
Living in the same regiona | 2042 (80%) | 1117 (70%) | 925 (95%) | <0.001 |
CD4+ at registration | 169 (59–328) | 159 (50–332) | 185 (74–323) | 0.03 |
WHO stage at registration | 3 (3–3) | 3 (3–4) | 3 (1–3) | <0.001 |
Prescribed TDF + FTC + EFV | 2280 (86%) | 1420 (85%) | 860 (89%) | 0.005 |
CD4+ change after ART (cells/mm3) | 148 (46–263) | 141 (44–258) | 166 (52–276) | 0.19 |
Required anti-tuberculosis treatment | 1124 (43%) | 691 (41%) | 433 (45%) | 0.09 |
Isoniazid prophylaxis therapy | 21 (0.8%) | 0 | 21 (2%) | <0.001 |
Co-trimoxazole prophylaxis therapy | 2125 (81%) | 1254 (76%) | 871 (90%) | <0.001 |
Died | 151 (5.7%) | 116 (7.3%) | 35 (3.7%) | <0.001 |
Lost to follow up | 111 (4.2%) | 89 (5.3%) | 22 (2.3%) | <0.001 |